<code id='DA704F8AF5'></code><style id='DA704F8AF5'></style>
    • <acronym id='DA704F8AF5'></acronym>
      <center id='DA704F8AF5'><center id='DA704F8AF5'><tfoot id='DA704F8AF5'></tfoot></center><abbr id='DA704F8AF5'><dir id='DA704F8AF5'><tfoot id='DA704F8AF5'></tfoot><noframes id='DA704F8AF5'>

    • <optgroup id='DA704F8AF5'><strike id='DA704F8AF5'><sup id='DA704F8AF5'></sup></strike><code id='DA704F8AF5'></code></optgroup>
        1. <b id='DA704F8AF5'><label id='DA704F8AF5'><select id='DA704F8AF5'><dt id='DA704F8AF5'><span id='DA704F8AF5'></span></dt></select></label></b><u id='DA704F8AF5'></u>
          <i id='DA704F8AF5'><strike id='DA704F8AF5'><tt id='DA704F8AF5'><pre id='DA704F8AF5'></pre></tt></strike></i>

          Home / entertainment / focus

          focus


          focus

          author:fashion    Page View:16
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In